PMC4802569_01
Cutaneous metastases before (A) and 13 months after (B) short-term vemurafenib treatment.
gr1.jpg
PMC4802569_01_gr1.jpg
fig1
Surprisingly, follow-up computed tomography scans showed continuous partial regression of all metastases during the subsequent months (Fig 1, Fig 2, A and B).
Pulmonary metastasis before (A) and 19 months after (B) short-term vemurafenib treatment.
gr2.jpg
PMC4802569_01_gr2.jpg
fig2
Surprisingly, follow-up computed tomography scans showed continuous partial regression of all metastases during the subsequent months (Fig 1, Fig 2, A and B).